[/+F6-P7YN}YV{)OI&%T<_!:U[~OR.ZFQ--+0Q)
SYSTEM PROCESSING...
[/+F6-P7YN}YV{)OI&%T<_!:U[~OR.ZFQ--+0Q)
SYSTEM PROCESSING...
Posted: 2025-04-20 13:06:52 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-20 13:06:58 UTC
Verified By
Rollup News
The REGENCY phase 3 trial showed that obinutuzumab plus standard therapy significantly improved renal responses in lupus nephritis patients compared to standard therapy alone.
Obinutuzumab plus standard therapy shows better renal responses in lupus nephritis patients.
Humanized type II anti-CD20 monoclonal antibody.